stoxline Quote Chart Rank Option Currency Glossary
  
Geron Corporation (GERN)
3.35  -0.13 (-3.74%)    05-28 16:00
Open: 3.47
High: 3.52
Volume: 8,623,838
  
Pre. Close: 3.48
Low: 3.3
Market Cap: 1,987(M)
Technical analysis
2024-05-28 4:53:03 PM
Short term     
Mid term     
Targets 6-month :  4.57 1-year :  5.02
Resists First :  3.91 Second :  4.3
Pivot price 3.72
Supports First :  3.29 Second :  2.74
MAs MA(5) :  3.53 MA(20) :  3.77
MA(100) :  2.81 MA(250) :  2.6
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  6.7 D(3) :  6.6
RSI RSI(14): 38.6
52-week High :  4.3 Low :  1.63
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ GERN ] has closed below the lower bollinger band by 7.4%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 15.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.54 - 3.58 3.58 - 3.6
Low: 3.23 - 3.27 3.27 - 3.3
Close: 3.3 - 3.37 3.37 - 3.41
Company Description

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Headline News

Tue, 28 May 2024
Geron (NASDAQ:GERN) Trading Down 4.9% - MarketBeat

Tue, 28 May 2024
Here's Why It's Unlikely That Geron Corporation's (NASDAQ:GERN) CEO Will See A Pay Rise This Year - Yahoo Movies UK

Mon, 27 May 2024
BNP Paribas Financial Markets Purchases 196328 Shares of Geron Co. (NASDAQ:GERN) - Defense World

Mon, 27 May 2024
Swiss National Bank Sells 232900 Shares of Geron Co. (NASDAQ:GERN) - Defense World

Sun, 26 May 2024
Are Options Traders Betting on a Big Move in Geron (GERN) Stock? - Yahoo Lifestyle UK

Thu, 23 May 2024
Geron Corporation: A High-Risk Deal With A Good Chance Of Success (NASDAQ:GERN) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out -109 (M)
Shares Float 0 (M)
Held by Insiders 5.9313e+008 (%)
Held by Institutions 5.4616e+008 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.35
Profit Margin 0 %
Operating Margin -18 %
Return on Assets (ttm) 465.1 %
Return on Equity (ttm) -29 %
Qtrly Rev. Growth 520000 %
Gross Profit (p.s.) -127.38
Sales Per Share -184.09
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.0953e+008 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio -2.3
Price to Book value -9.86
Price to Sales -0.02
Price to Cash Flow 0
Stock Dividends
Dividend 5.234e+007
Forward Dividend 4.666e+007
Dividend Yield 1562390000%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android